|
|
News for Healthier Living
RAS(ON) Inhibitor Doubles Median Overall Survival in Results of Phase 3 Trial for Patients with Metastatic Pancreatic Cancer
 A shift in the way people think about and treat pancreatic cancer could be on the horizon based on positive results from the pivotal randomized phase 3 RASolute 302 trial comparing daraxonrasib to chemotherapy as second-line therapy for patients with metastatic pancreatic cancer. Results will be presented in the plenary session by Brian Wolpin, MD, MPH, director of the Hale Family Center for Pancreatic Cancer Research and Gastrointestinal Cancer Center at Dana-Farber Cancer Institute at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on May 31, 2026, and will publish simultaneously in the New England Journal of Medicine.
May 31, 2026
May 31 2026May 30 2026May 29 2026May 28 2026May 27 2026May 26 2026May 25 2026May 22 2026May 21 2026May 20 2026 - Cedars-Sinai Research Identifies Drivers of Liver Disease
- Study Identifies New Marker to Find Patients with Advanced Prostate Cancer More Likely to Benefit From Combination Immunotherapy
- New Exhibit Explores Far-Reaching Impact of an Ancient Eye Disease
- The Neural Basis of Thought Symbols Identified for the First Time
- Can Wastewater Surveillance Work Without Sewers?
- First National Study of Home Care Safety for Children with Medical Complexity
- Tumor Microenvironment Features May Predict Immunotherapy Response in Rare Cancers
- Genetically Reengineered Bacteria Targets Cancerous Tumors
- Novel Blood Test Detects Rejection After Lung Transplant
- How Tetracyclines Work: New Study Redefines Mechanism-of-Action
- FL118 Granted FDA Rare Pediatric Disease Designation and Orphan Drug Designation for Osteosarcoma
- In Middle-Aged and Older Adults, Migraine with Aura Associated with Higher Stroke Risk
- Quitting Smoking Associated with Lower Dementia Risk
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- Positional Therapy Offers Lasting Benefits for Most Positional OSA Patients
- Early CPAP Struggles Don't Predict Treatment Failure, Study Finds
- Your Handwriting Could Be a Window Into Your Aging Brain
- Nearly 10% of Surgeons are Leaving the Profession Within 8 Years
- Pilot Trial Suggests Anti-Inflammatory Drug Could Help Difficult-to-Treat Depression
- No Meaningful Health Impacts From Exposure to Wind Turbines
- Cytokine-Armored CAR-T Cell Therapy Helps Eliminate Aggressive Brain Tumors in Preclinical Study
- Study Suggests Novel Way to Protect Aging Brains After Surgery
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Could K17 be a Key Treatment Target for Pancreatic Cancer?
- Endocrine Society, Keystone Symposia to Host First Joint Conference in October
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- BGSU Scientists Make Groundbreaking Discovery - and Find a Possible New Ally - in the Opioid Crisis
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Ozone Pollution Limits Lung Benefits of Exercise in Children
- Squeezed and Sped Up: Viscous Stress Primes Glioblastoma Cells for Invasion
- Study: Hospital Wastewater Reveals Drug-Resistant Fungus Strains Months Before Patients Show Symptoms
- Saliva Could Flag One of SA's Deadliest and Baffling Cancers Sooner
- AI Foundation Models Offer a New Vision for Eye Care
May 19 2026May 18 2026May 17 2026
|
|
|
|
|